Clinical Trial Update: TIL Therapy in cSCC and MCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tumor-infiltrating lymphocyte therapy for cutaneous squamous cell carcinoma and Merkel cell carcinoma is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Merkel Cell Carcinoma

Drugs mentioned

• Tumor-infiltrating lymphocyte (TIL) therapy

Snippet

Sponsor: Karam Khaddour, MD, MS | Conditions: Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma | Phase 2 | Status: RECRUITING